During the corresponding time, Elevance Health Inc recorded a revenue increase by 2.64 % year on year, sequentially revenue grew by 0.87 %. While revenue at the Elevance Health Inc 's corporate clients
Elevance Health Inc's Comment on Sales, Marketing and Customers
As of December 31, 2025, the company serves approximately 45.2 million medical members through affiliated health plans. It offers network-based managed care risk plans to individual, employer group, Medicaid, and Medicare markets. Services include managed care for fee-based customers, claims processing, stop loss insurance, provider network access, medical and care management, wellness programs, actuarial services, and other administrative functions. Revenue is derived from risk-based premiums, administrative fees from self-funded employers, and pharmacy and health service fees through Carelon businesses.
The company provides services to the federal government through its Federal Health Products & Services business, administering the Federal Employee Program (FEP). Specialty services offered to subsidiary and unaffiliated health plans include pharmacy services, stop loss insurance, dental, vision, supplemental health insurance benefits, and integrated health services.
Operating as an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), the company serves as the Blue Cross licensee for California and the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (New York City metro area and upstate), Ohio, Virginia (excluding Northern Virginia suburbs of Washington, D.C.), and Wisconsin. It conducts business primarily under the Anthem Blue Cross and Anthem Blue Cross and Blue Shield names, and also operates under the Wellpoint, Carelon, MMM, and Simply Healthcare brands in various states.
The company is licensed to conduct insurance operations in all 50 states, the District of Columbia, and Puerto Rico through subsidiaries. Pharmacy services are provided through CarelonRx, with additional healthcare-related services offered through Carelon Services. Its core go-to-market brands include Anthem Blue Cross/Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon. The company reports its operations in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Elevance Health to Present at Barclays Global Healthcare ConferenceINDIANAPOLIS - Elevance Health (NYSE: ELV), a leading healthcare company, announced today that its senior management is scheduled to present at the Barclays 26th Annual Global Healthcare Conference in Miami. The presentation will take place on March 14 at 9:30 a.m. Eastern Daylight Time (EDT).The event, one of the most significant conferences in the healthcare industry, offers a platform for companies to showcase their recent developments, strategies, and financial outlook to potential investors and other interested parties. Elevance Health will be sharing insights into their innovative solutions and future plans to further advance healthcare...
Elevance Health Inc’s Comment on Sales, Marketing and Customers
As of December 31, 2025, the company serves approximately 45.2 million medical members through affiliated health plans. It offers network-based managed care risk plans to individual, employer group, Medicaid, and Medicare markets. Services include managed care for fee-based customers, claims processing, stop loss insurance, provider network access, medical and care management, wellness programs, actuarial services, and other administrative functions. Revenue is derived from risk-based premiums, administrative fees from self-funded employers, and pharmacy and health service fees through Carelon businesses.
The company provides services to the federal government through its Federal Health Products & Services business, administering the Federal Employee Program (FEP). Specialty services offered to subsidiary and unaffiliated health plans include pharmacy services, stop loss insurance, dental, vision, supplemental health insurance benefits, and integrated health services.
Operating as an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), the company serves as the Blue Cross licensee for California and the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (New York City metro area and upstate), Ohio, Virginia (excluding Northern Virginia suburbs of Washington, D.C.), and Wisconsin. It conducts business primarily under the Anthem Blue Cross and Anthem Blue Cross and Blue Shield names, and also operates under the Wellpoint, Carelon, MMM, and Simply Healthcare brands in various states.
The company is licensed to conduct insurance operations in all 50 states, the District of Columbia, and Puerto Rico through subsidiaries. Pharmacy services are provided through CarelonRx, with additional healthcare-related services offered through Carelon Services. Its core go-to-market brands include Anthem Blue Cross/Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon. The company reports its operations in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Sources:
Elevance Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Elevance Health Inc’s corporate clients.
For your research, we’ve provided 9 tables on Elevance Health Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
12.41 %